BAVARIAN NORDIC, INC.

Bavarian Nordic, Inc. specializes in the manufacturing of advanced pharmaceutical preparations, with a focused expertise in vaccine development and production for public health programs. The company delivers critical immunization products tailored for adult and pediatric populations, aligning with federal immunization guidelines and regulatory standards for biologics manufacturing. Their technical capabilities encompass aseptic processing, cold chain logistics, and compliance with cGMP protocols for vaccine formulation, filling, and packaging. A key differentiator is their ability to support time-sensitive, large-scale public health initiatives requiring rapid scalability and stringent quality control across the product lifecycle. The contractor has established direct relationships with the Department of Health and Human Services and the Department of Veterans Affairs, delivering vaccines under programs such as the Vaccines for Children initiative and the Federal Supply Schedule for pharmaceuticals. These engagements reflect a pattern of sustained partnership in supporting national immunization infrastructure and veteran healthcare readiness, with work centered on the procurement and supply of FDA-regulated biologics. Their primary industry focus is in NAICS 325412 — Pharmaceutical Preparation Manufacturing — where they operate within the biologics and vaccine segment of the pharmaceutical supply chain. This positions them as a specialized provider of immunization solutions for government-funded public health and clinical care systems, distinct from general pharmaceutical distributors or small-molecule manufacturers. As a 2L entity based in Durham, North Carolina, Bavarian Nordic, Inc. operates as a mid-tier manufacturer with no federal certifications on record. Their geographic presence is anchored in the U.S. biopharma corridor, supporting federal procurement needs through direct manufacturing and supply chain reliability rather than third-party distribution models.